Shanghai Smartee Denti-Technology Co., Ltd.

Shanghai Smartee Denti-Technology Co., Ltd., commonly known as Smartee, is a global provider of invisible orthodontic solutions. Established in 2004, the company focuses on the research, development, and manufacturing of clear aligners. Its global headquarters are located in Shanghai, China, with a European headquarters situated in Madrid, Spain.

Smartee offers a comprehensive portfolio of clear aligner products and digital orthodontic solutions designed for various malocclusion problems across children, adolescents, and adults. Key offerings include the Smartee GS, GE, α, Kinder, and Teen aligner series. The company integrates advanced technologies such as proprietary mandibular repositioning technology, digital workflow systems like SmarteeCheck, intraoral scanning devices, and specialized dental sheets to provide precise and effective treatment options to orthodontists and dental clinics worldwide.

With over two decades of innovation, Smartee has expanded its global footprint, serving over 83,000 doctors in 47 countries as of early 2025, and over 91,000 doctors from 71,000 medical institutions as of March 2025. The company holds a significant intellectual property portfolio with over 750 patents. Recent developments include the launch of a 100,000 square meter sustainable clear aligner factory in 2025, strategic expansion into Malaysia in March 2026, and a partnership with the Straumann Group in late 2025. Smartee also introduced new material and trimline selection features for enhanced aligner customization in April 2026. The company is privately held and closed a Series D funding round of CNY 500 million in 2022. Mr. Junfeng Yao is recognized as the founder of Smartee.

Latest updates

Smartee Denti-Technology's New Classification System Could Reshape Orthodontic Treatment

Event summary

  • Smartee Denti-Technology's Chief Scientist, Professor Gang Shen, published a new classification system for malocclusions in the Journal of Aligner Orthodontics (JAO) on April 30, 2026.
  • The system expands upon the traditional Angle classification by incorporating facial morphology, mandibular position, TMJ health, and curve of Spee.
  • The research introduces 'Mandibular Morphology Analysis' to categorize patients into 'Flat-Rectangular Mandible' and 'Thick-Triangular Mandible' groups.
  • The classification system underpins Smartee’s Mandibular Advancement Repositioning Technology (MART) and the S8-SGTB appliance.
  • Radiographic data suggests MART can facilitate adaptive TMJ remodeling, potentially offering a non-surgical treatment option.

The big picture

Smartee Denti-Technology’s move to redefine malocclusion diagnosis aligns with the broader trend towards personalized and data-driven healthcare. The company’s focus on mandibular advancement technology positions it to capitalize on the growing demand for non-surgical orthodontic solutions, particularly among adult patients. However, the success of this strategy hinges on the clinical validation of the new classification system and the acceptance of MART by the orthodontic community.

What we're watching

Clinical Adoption
The speed at which orthodontists adopt Professor Shen's new classification system will determine the near-term impact on Smartee’s GS product line sales and market share.
Regulatory Scrutiny
The claim of adaptive TMJ remodeling through MART will likely draw scrutiny from regulatory bodies, potentially impacting the approval and reimbursement pathways for the S8-SGTB.
Competitive Response
Competitors in the clear aligner market will likely attempt to develop competing diagnostic frameworks and treatment protocols, intensifying competition and potentially eroding Smartee’s technological advantage.

Smartee Adds Customization Options, Signals Shift in Aligner Precision

Event summary

  • Smartee Denti-Technology introduced Material Choice (Softer/Standard) and Trimline Selection (Classic Scalloped, Scalloped Extended, Straight) features to its SmarteeCheck digital case management system.
  • The new features are available globally for all new case approvals, effective March 31, 2026.
  • Material Choice allows clinicians to select aligner material based on treatment phase needs (comfort vs. force).
  • Trimline Selection offers three distinct styles, informed by recent clinical studies on aligner biomechanics and aesthetics.
  • Smartee cites research from BMC Oral Health and AJODO to justify the trimline options, highlighting their impact on force delivery, retention, and patient perception.

The big picture

Smartee’s introduction of material and trimline selection represents a move towards greater personalization in clear aligner therapy, reflecting a growing emphasis on patient comfort and clinical precision. This shift, supported by emerging clinical research, suggests a potential fragmentation of the aligner market, where customized solutions gain prominence over standardized offerings. The move also highlights the increasing importance of data-driven design in medical devices, as Smartee explicitly references published studies to justify its feature additions.

What we're watching

Adoption Rate
The speed at which clinicians adopt these new features will indicate the perceived value and ease of use within Smartee’s existing user base, and potentially attract new customers.
Competitive Response
Other clear aligner manufacturers will likely evaluate Smartee’s move and may introduce similar customization options, intensifying competition and potentially driving down margins.
Clinical Validation
Long-term clinical data demonstrating the impact of material and trimline choices on treatment outcomes will be crucial to solidify Smartee’s position and justify the feature set.

Smartee Denti-Technology Enters Malaysia, Targeting AI-Driven Orthodontics Growth

Event summary

  • Smartee Denti-Technology launched operations in Malaysia on March 27, 2026, following a clinical conference held on March 16, 2026.
  • The conference hosted over 70 Malaysian dental professionals, including specialists and faculty.
  • Smartee's product suite, including GS, α (Alpha), GE, Teen, and Kinder series, was showcased, emphasizing advanced biomechanics and AI-driven tools.
  • Smartee operates a network of over 99,000 partner doctors across 57 countries and has four global production bases.

The big picture

Smartee's expansion into Malaysia reflects the broader trend of increasing demand for aesthetic dentistry solutions in Southeast Asia, fueled by rising disposable incomes and technological advancements. The company's focus on AI-driven tools and clinical training signals a strategy to differentiate itself from competitors and establish a premium position within the market. This move also highlights the growing importance of emerging markets for global medical device companies seeking growth beyond established Western economies.

What we're watching

Market Adoption
The pace at which Malaysian clinicians integrate Smartee’s advanced AI tools into their practices will determine the speed of market penetration and overall revenue generation.
Competitive Response
Existing clear aligner providers in Malaysia will likely respond to Smartee’s entry, potentially through price adjustments or accelerated product innovation, impacting Smartee’s market share.
Regulatory Landscape
Changes in Malaysian regulations regarding medical device approvals and data privacy could significantly affect Smartee’s operational costs and market access.

Smartee's European Expansion Accelerates with Manufacturing, Clinical Hubs

Event summary

  • Smartee Denti-Technology showcased its Mandibular Repositioning Technology at the ALIGNEA 2026 congress in Salamanca, Spain, from February 19-21.
  • The company has established manufacturing and clinical support hubs in Spain (Madrid, 2024) and the UK (Stoke-on-Trent, October 2025).
  • Dr. Te Wang delivered a keynote presentation on using the S8-SGTB clear aligner to correct Class II jaw discrepancies.
  • Smartee now serves over 99,000 partner doctors across 57 countries with dual manufacturing capabilities in China and Spain.
  • Smartee integrated Marvel’s Iron Man visual elements into its exhibition booth to humanize the orthodontic practice.

The big picture

Smartee's European expansion reflects a broader trend of dental technology companies seeking to localize production and support to better serve regional markets and navigate evolving regulatory landscapes. The company’s focus on mandibular repositioning technology and sleep apnea treatment positions it within a growing market for integrated dental and sleep health solutions. The use of pop culture branding is a risky but potentially high-reward strategy to appeal to younger patients and differentiate from competitors in a traditionally conservative sector.

What we're watching

Regional Adoption
The success of Smartee's European localization strategy hinges on the ability to adapt its solutions to diverse clinical practices and regulatory environments across the continent.
Clinical Validation
Wider adoption of the S8-SGTB technology will depend on continued clinical validation and evidence demonstrating its efficacy compared to traditional treatments like orthognathic surgery.
Brand Perception
Smartee’s novel use of pop culture to engage patients may prove a sustainable differentiator, but its long-term impact on brand perception within the medical community remains to be seen.

Smartee's MART Training Signals Australian Clear Aligner Market Push

Event summary

  • Smartee Denti-Technology held a 'Mandibular Repositioning' Master Class in Sydney on February 7, 2026, at the invitation of EODO.
  • The Master Class attracted 80 dental professionals (60 in-person, 20 online).
  • Smartee’s Mandibular Advancement Repositioning Technology (MART) has been used in over 100,000 cases globally.
  • The Australian clear aligner market is experiencing strong patient-driven demand and a preference for aesthetic solutions.

The big picture

Smartee’s investment in clinical education, rather than direct sales, suggests a long-term strategy to establish MART as a standard of care in the clear aligner market. This approach contrasts with typical go-to-market strategies and signals an intent to build a sustainable competitive advantage through professional relationships. The Australian market’s strong patient demand for aesthetic treatments provides a fertile ground for Smartee's expansion, but success hinges on convincing practitioners of MART's value proposition.

What we're watching

Market Penetration
How Smartee’s educational approach will impact its ability to displace established players in the Australian clear aligner market, given the existing preference for aesthetic solutions.
Clinical Adoption
Whether the demonstrated clinical success of MART, as highlighted by the Master Class, translates into widespread adoption by Australian dental professionals.
Competitive Response
The pace at which competitors will respond to Smartee’s MART training program and its focus on orthopedic correction, potentially leading to a new wave of innovation in the clear aligner space.

Smartee Denti-Technology Targets Middle East with Advanced Aligner Technology

Event summary

  • Smartee Denti-Technology introduced its GS Mandibular Advancement Repositioning Technology (MART) at AEEDC Dubai 2026.
  • The technology aims to treat severe skeletal Class II malocclusions, a common issue in the Middle East.
  • Smartee presented a new classification system for malocclusions based on facial convexity, concavity, and mandibular deviation.
  • The company serves over 99,000 doctors in 57 countries and has four R&D centers and four manufacturing bases.
  • International Sales Director Garie Zhou highlighted the region's demand for solutions bridging efficiency and biological stability.

The big picture

Smartee's move signals a broader trend of digital orthodontic solutions expanding beyond simple tooth alignment to address more complex skeletal issues. The Middle East represents a strategic growth market due to its high adoption rate of digital dentistry and increasing patient demand for aesthetic procedures. This expansion requires Smartee to balance technological innovation with robust clinical validation and effective training programs to ensure successful market penetration.

What we're watching

Market Adoption
The success of MART will depend on the willingness of Middle Eastern orthodontists to adopt the new protocols and integrate them into their practices, potentially requiring significant training and workflow adjustments.
Clinical Validation
Independent clinical studies will be crucial to validate Smartee's claims of TMJ remodeling and improved facial profiles, as these are key differentiators for the technology.
Competitive Response
Other clear aligner manufacturers will likely respond to Smartee’s advancements with their own innovations, intensifying competition and potentially eroding Smartee’s market share if they fail to maintain a technological lead.

Smartee's Manufacturing Partnership with Straumann Signals Clear Aligner Consolidation

Event summary

  • Smartee Denti-Technology reached 100,000 cases utilizing its GS Mandibular Repositioning technology in 2025.
  • The company launched a 100,000-square-meter intelligent manufacturing campus to expand production capacity.
  • Smartee entered a strategic partnership with Straumann Group to provide manufacturing support for ClearCorrect in EMEA and APAC markets.
  • Smartee introduced two new technologies: Smartee Sleep Aligner (for sleep apnea) and Smartee Live 3D (an AI-powered treatment planning tool).

The big picture

Smartee's rapid expansion and strategic partnership with Straumann indicate a maturing market for digital orthodontics. The company’s focus on clinical validation and manufacturing scale-up positions it to capitalize on the growing demand for clear aligner solutions, but also introduces complexities in managing a larger, more geographically diverse operation. The partnership with Straumann, a major player in dental implant technology, suggests a broader trend of integration within the dental device ecosystem.

What we're watching

Market Dynamics
The Straumann partnership suggests a potential shift towards consolidation within the clear aligner market, as larger players seek to leverage specialized manufacturing capabilities.
Clinical Adoption
The continued publication of research validating Smartee’s mandibular repositioning protocols will be critical for driving broader adoption among orthodontists and influencing reimbursement policies.
Execution Risk
Smartee’s ability to effectively manage the increased production volume and maintain product consistency while supporting Straumann’s ClearCorrect brand will be a key determinant of future success.

Smartee's Manufacturing Partnership Signals Clear Aligner Consolidation

Event summary

  • Smartee Denti-Technology reached 100,000 cases utilizing its GS Mandibular Repositioning technology in 2025.
  • The company launched a 100,000-square-meter intelligent manufacturing campus to expand production capacity.
  • Smartee entered a strategic partnership with Straumann Group to manufacture ClearCorrect aligners in EMEA and APAC markets.
  • Smartee introduced two new products: Smartee Sleep Aligner (for sleep apnea) and Smartee Live 3D (an AI-powered treatment planning tool).
  • The company expanded its global footprint with a UK subsidiary and a European clinical support center in Stoke-on-Trent.

The big picture

Smartee's rapid expansion and partnership with Straumann highlight the ongoing consolidation within the digital orthodontics market. The company's focus on manufacturing scale and AI-driven efficiency positions it to capitalize on the growing demand for clear aligner treatments globally. The entry into the sleep apnea market represents a strategic diversification, but also introduces new regulatory and clinical challenges.

What we're watching

Competitive Landscape
The Straumann partnership suggests Smartee is positioning itself as a contract manufacturer, which could intensify competition within the clear aligner space as other players seek similar outsourcing options.
Clinical Adoption
The pace at which the 100,000-case milestone translates into broader adoption of mandibular repositioning techniques will depend on continued publication of positive clinical outcomes and acceptance by orthodontists.
Regulatory Scrutiny
As Smartee expands its sleep apnea device offerings, increased regulatory scrutiny of these devices, particularly regarding efficacy and patient safety, could impact growth and market access.
CID: 773